Whole-Organ Pancreas and Islets Transplantations in UK: An Overview and Future Directions

Whole-organ pancreas and islets transplantations are two therapeutic options to treat type 1 diabetic patients resistant to optimised medical treatment in whom severe complications develop. Selection of the best option for β-cell replacement depends on several factors such as kidney function, patien...

Full description

Bibliographic Details
Main Authors: David Martin, Piero Alberti, Nicolas Demartines, Melanie Phillips, John Casey, Andrew Sutherland
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/12/9/3245
_version_ 1797602332773449728
author David Martin
Piero Alberti
Nicolas Demartines
Melanie Phillips
John Casey
Andrew Sutherland
author_facet David Martin
Piero Alberti
Nicolas Demartines
Melanie Phillips
John Casey
Andrew Sutherland
author_sort David Martin
collection DOAJ
description Whole-organ pancreas and islets transplantations are two therapeutic options to treat type 1 diabetic patients resistant to optimised medical treatment in whom severe complications develop. Selection of the best option for β-cell replacement depends on several factors such as kidney function, patient comorbidities, and treatment goals. For a patient with end-stage kidney disease, the treatment of choice is often a simultaneous transplant of the pancreas and kidney (SPK). However, it remains a major surgical procedure in patients with multiple comorbidities and therefore it is important to select those who will benefit from it. Additionally, in view of the organ shortage, new strategies to improve outcomes and reduce immune reactions have been developed, including dynamic organ perfusion technologies, pancreas bioengineering, and stem cell therapies. The purpose of this article is to review the indications, surgical techniques, outcomes, and future directions of whole-organ pancreas and islets transplantations.
first_indexed 2024-03-11T04:15:36Z
format Article
id doaj.art-d8cc3a3856344f1eae53f7dc78066cb6
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-11T04:15:36Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-d8cc3a3856344f1eae53f7dc78066cb62023-11-17T23:12:37ZengMDPI AGJournal of Clinical Medicine2077-03832023-05-01129324510.3390/jcm12093245Whole-Organ Pancreas and Islets Transplantations in UK: An Overview and Future DirectionsDavid Martin0Piero Alberti1Nicolas Demartines2Melanie Phillips3John Casey4Andrew Sutherland5Department of Visceral Surgery and Transplantation, University Hospital CHUV, University of Lausanne (UNIL), 1015 Lausanne, SwitzerlandEdinburgh Transplant Centre, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, UKDepartment of Visceral Surgery and Transplantation, University Hospital CHUV, University of Lausanne (UNIL), 1015 Lausanne, SwitzerlandEdinburgh Transplant Centre, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, UKEdinburgh Transplant Centre, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, UKEdinburgh Transplant Centre, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, UKWhole-organ pancreas and islets transplantations are two therapeutic options to treat type 1 diabetic patients resistant to optimised medical treatment in whom severe complications develop. Selection of the best option for β-cell replacement depends on several factors such as kidney function, patient comorbidities, and treatment goals. For a patient with end-stage kidney disease, the treatment of choice is often a simultaneous transplant of the pancreas and kidney (SPK). However, it remains a major surgical procedure in patients with multiple comorbidities and therefore it is important to select those who will benefit from it. Additionally, in view of the organ shortage, new strategies to improve outcomes and reduce immune reactions have been developed, including dynamic organ perfusion technologies, pancreas bioengineering, and stem cell therapies. The purpose of this article is to review the indications, surgical techniques, outcomes, and future directions of whole-organ pancreas and islets transplantations.https://www.mdpi.com/2077-0383/12/9/3245pancreas transplantationislets transplantationtype 1 diabetes mellitus
spellingShingle David Martin
Piero Alberti
Nicolas Demartines
Melanie Phillips
John Casey
Andrew Sutherland
Whole-Organ Pancreas and Islets Transplantations in UK: An Overview and Future Directions
Journal of Clinical Medicine
pancreas transplantation
islets transplantation
type 1 diabetes mellitus
title Whole-Organ Pancreas and Islets Transplantations in UK: An Overview and Future Directions
title_full Whole-Organ Pancreas and Islets Transplantations in UK: An Overview and Future Directions
title_fullStr Whole-Organ Pancreas and Islets Transplantations in UK: An Overview and Future Directions
title_full_unstemmed Whole-Organ Pancreas and Islets Transplantations in UK: An Overview and Future Directions
title_short Whole-Organ Pancreas and Islets Transplantations in UK: An Overview and Future Directions
title_sort whole organ pancreas and islets transplantations in uk an overview and future directions
topic pancreas transplantation
islets transplantation
type 1 diabetes mellitus
url https://www.mdpi.com/2077-0383/12/9/3245
work_keys_str_mv AT davidmartin wholeorganpancreasandisletstransplantationsinukanoverviewandfuturedirections
AT pieroalberti wholeorganpancreasandisletstransplantationsinukanoverviewandfuturedirections
AT nicolasdemartines wholeorganpancreasandisletstransplantationsinukanoverviewandfuturedirections
AT melaniephillips wholeorganpancreasandisletstransplantationsinukanoverviewandfuturedirections
AT johncasey wholeorganpancreasandisletstransplantationsinukanoverviewandfuturedirections
AT andrewsutherland wholeorganpancreasandisletstransplantationsinukanoverviewandfuturedirections